INTERLEUKIN GENETICS INC (CIK: 0001037649) EDGAR, Information, Filings... CompaniesBIO.Com

INTERLEUKIN GENETICS INC

Mailing address
135 BEAVER ST, WATHAM, Delaware, 02452
Phone
1-781-398-0700
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Filings
N/A

INTERLEUKIN GENETICS INC (CIK: 0001037649) is an American company incorporated in the state of Massachusetts. Head office is located at 135 BEAVER ST, WATHAM, Massachusetts, 02452. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. INTERLEUKIN GENETICS INC is a public company and trade via Over-The-Counter (OTC).

Old names:

MEDICAL SCIENCE SYSTEMS INC from 1997-21-Nov to 1999-30-Apr

Owner	Filings	Transaction Date	Type of Owner
Toutain Stephan	0001681658	Aug-15-2016	officer: Chief Commercial Officer
BAY CITY CAPITAL LLC	0001288452	Jul-29-2016	10 percent owner
Bay City Capital Fund V, L.P.	0001401826	Jul-29-2016	10 percent owner
Bay City Capital Fund V Co-Investment Fund, L.P.	0001409813	Jul-29-2016	10 percent owner
Bay City Capital Management V LLC	0001461543	Jul-29-2016	10 percent owner
Carbeau Mark B	0001339155	Apr-06-2015	director, officer: Chief Executive Officer
DiPalma Stephen J.	0001426479	Sep-08-2014	officer: Interim CFO
Landstra Joseph M	0001604585	Mar-31-2014	director
BARRIS PETER J	0001005561	May-17-2013	10 percent owner
BARRETT M JAMES	0001219855	May-17-2013	10 percent owner
MOTT DAVID M	0001219871	May-17-2013	10 percent owner
KERINS PATRICK J	0001235112	May-17-2013	10 percent owner
SANDELL SCOTT D	0001237289	May-17-2013	10 percent owner
KOLLURI KRISHNA KITTU	0001270521	May-17-2013	10 percent owner
BASKETT FOREST	0001277631	May-17-2013	10 percent owner
DRANT RYAN D	0001302106	May-17-2013	10 percent owner
Weller Harry R	0001362942	May-17-2013	10 percent owner
Misfeldt Dayton	0001461466	May-17-2013	director
Viswanathan Ravi	0001479386	May-17-2013	10 percent owner
New Enterprise Associates 14, L.P.	0001544328	May-17-2013	10 percent owner
Growth Equity Opportunities Fund III, LLC	0001551055	May-17-2013	10 percent owner
NEA Partners 14, L.P.	0001551531	May-17-2013	10 percent owner
NEA 14 GP, LTD	0001551532	May-17-2013	10 percent owner
Sonsini Peter W.	0001559807	May-17-2013	10 percent owner
Florence Anthony A. Jr.	0001559827	May-17-2013	10 percent owner
Carnot Lionel	0001577049	May-17-2013	director
Snyder Scott A.	0001565556	Jan-02-2013	officer: Chief Marketing Officer
Delta Dental Plan of Michigan, Inc.	0001552918	Jun-29-2012	10 percent owner
Jurkovic Goran	0001578172	Jun-29-2012	director
Ehrenberger Catherine	0001498300	Jul-30-2010	director
Mills William C. III	0001298690	Apr-29-2010	director
CHOWNING MARY E	0001257133	Jul-24-2008	director
Armstrong Glenn S	0001440929	Jul-24-2008	director
KORNMAN KENNETH S	0001237192	May-01-2008	director, officer: President & CSO
Lurier Eliot M	0001438037	Apr-30-2008	officer: Chief Financial Officer
BENDER LEWIS H	0001238705	Jan-22-2008	officer: Chief Executive Officer
WEAVER JAMES M	0001257134	Jul-02-2007	director
Richerson Timothy J	0001373593	Aug-17-2006	officer: Chief Executive Officer
Finkelstein David A	0001373776	Aug-17-2006	officer: Chief Strategy Officer
Bennett Dianne E	0001365761	Jun-06-2006	director
Mayer Gregg Thomas	0001358627	Apr-03-2006	officer: Chief Business Officer
MCCABE JOHN J	0001205535	Aug-15-2005	officer: Chief Accounting Officer
Mohanlal Ramon W MD	0001332422	Jul-01-2005	officer: Chief Medical Officer
Viveen William J JR	0001304185	Sep-15-2004	director
Alticor Global Holdings Inc.	0001303680	Jul-28-2004	10 percent owner
ELOI FENEL M	0001237190	Dec-11-2003	officer: Chief Financial Officer
REILLY PHILIP R	0001237194	Oct-10-2003	director, officer: Chief Executive Officer
ALTICOR INC	0000941980	Jun-30-2003	other: Parent Holding Company
PYXIS INNOVATIONS INC	0001221575	Jun-30-2003	10 percent owner
ALTICOR HOLDINGS INC	0001257877	Jun-30-2003	other: Parent Holding Company
GAROFALO STEPHEN A	0001053791	Apr-01-2003	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by INTERLEUKIN GENETICS INC

Filings	Format	Description	Filed/Effective	File/Film Number
15-12B	Document	Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001144204-17-042613 (34 Act) Size: 11 KB	Aug-14-2017	001-32715 171026814
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950138-17-000591 (34 Act) Size: 119 KB	Aug-04-2017	005-53249 171008072
DEF 14A	Document	Definitive proxy statements Acc-no: 0001144204-17-040482 (34 Act) Size: 2012 KB	Aug-04-2017	001-32715 171007405
25	Document	Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange Acc-no: 0001144204-17-040438 (34 Act) Size: 14 KB	Aug-04-2017	001-32715 171006916
8-K	Document	Current report filing Acc-no: 0001144204-17-037849 (34 Act) Size: 24 KB	Jul-24-2017	001-32715 17978483
8-K	Document	Current report filing Acc-no: 0001144204-17-035350 (34 Act) Size: 28 KB	Jul-03-2017	001-32715 17944178
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001144204-17-026826 ( Act) Size: 5 KB	May-12-2017
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-17-026502 (34 Act) Size: 3356 KB	May-11-2017	001-32715 17835184
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001144204-17-023593 (34 Act) Size: 265 KB	May-01-2017	001-32715 17800118
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001144204-17-020895 (34 Act) Size: 5119 KB	Apr-18-2017	001-32715 17766933
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001144204-17-020760 (34 Act) Size: 1031 KB	Apr-17-2017	001-32715 17765417
NT 10-K	Document	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001144204-17-018568 (34 Act) Size: 21 KB	Apr-03-2017	001-32715 17735128
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001144204-17-018367 (33 Act) Size: 29 KB	Apr-03-2017	333-213595 17732470
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001144204-17-018366 (33 Act) Size: 29 KB	Apr-03-2017	333-201908 17732467
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001144204-17-018365 (33 Act) Size: 29 KB	Apr-03-2017	333-189749 17732465
8-K	Document	Current report filing Acc-no: 0001144204-17-018277 (34 Act) Size: 16 KB	Mar-31-2017	001-32715 17731392
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001144204-17-004109 ( Act) Size: 5 KB	Jan-26-2017
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001144204-17-004104 ( Act) Size: 5 KB	Jan-26-2017
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001144204-17-004102 ( Act) Size: 5 KB	Jan-26-2017
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001144204-17-004096 ( Act) Size: 5 KB	Jan-26-2017

Recent 20 filings. View all INTERLEUKIN GENETICS INC filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

INTERLEUKIN GENETICS INC overview
INTERLEUKIN GENETICS INC job
INTERLEUKIN GENETICS INC stock
INTERLEUKIN GENETICS INC ownership
INTERLEUKIN GENETICS INC CEO
INTERLEUKIN GENETICS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.